Delivery Of Esketamine For The Treatment Of Depression
AssigneeJanssen Pharmaceutica NV
InventorsJingli Wang, Michael Cannamela, Hong Yan, Rochelle Kleinberg
Life of this patent
Estimating the term…
Abstract
The present invention provides devices and methods for treating depression in a patient, comprising administering to the patient in need of the treatment a therapeutically effective amount of esketamine. In some embodiments, the depression is major depressive disorder or treatment resistant depression. In other embodiments, the therapeutically effective amount is clinically proven safe and/or effective. Also provided are methods to mitigate the risk or misuse or abuse of esketamine, instructions for use of the esketamine product, and methods for selling a drug product containing esketamine.
Claims6
A method for intranasally administering a drug, comprising dispensing said drug from a device that comprises:
- a proximal end, and a distal end that is offset from the proximal end along a distal direction;
- a housing configured to house a drug product therein;
- a plunger that extends from the proximal end towards the distal end along the distal direction, and that is translatable relative to the housing along the distal direction, and a proximal direction that is opposite the distal direction;
- a tip that extends from the distal end towards the proximal end and is configured to be received in a nasal passage;
- and
- a nose rest that extends outwardly away from the housing and that is configured to rest against a nostril when the tip is received in a nasal passage.
Dependencies are inferred from the claim text.